NORCROSS,SpectRx has named Bill Arthur as president and chief operating officer of the company effective immediately.

Arthur will lead SpectRx’s diabetes business, which includes SimpleChoice insulin pump disposable products and the development program for a continuous glucose monitor.

Previously, Arthur was vice president of sales for MiniMed, another provider of insulin pumps and supplies, which was sold to Medtronic in 2001 for $3.4 billion.

Arthur also has founded and served as CEO of MedFusion, a maker of infusion pumps and disposables for drug delivery. Earlier, he served in marketing capacities at Pacesetter Systems, the predecessor to MiniMed, Auto-Syringe Inc. and Becton-Dickinson.

“Bill is a proven leader in the area of insulin pump sales and marketing who knows how to get results,” said Mark A. Samuels, chairman and CEO of SpectRx. “Bill has a history of successfully introducing innovative products into the marketplace and helping grow companies into positions as market leaders. We believe that Bill is capable of helping rapidly build our diabetes business into a substantial market position.”

Most immediately, Arthur says he plans to complete the introduction of the company’s SimpleChoice products to the diabetes market and begin growing revenue. He says SpectRx also plans to move its continuous glucose monitoring development program by finding a technical and financial partner to bring the product to market quickly.

Keith Ignotz, in his role as senior executive vice president, will continue his focus on obtaining separate funding for the company’s cervical cancer development program.